Cerveau Technologies Inc. and LEXEO Therapeutics, Inc.- Sign

Cerveau Technologies Inc. and LEXEO Therapeutics, Inc.- Sign Agreement to Provide Novel Tau Imaging Biomarker for Disease Modifier Research

BOSTON — Cerveau Technologies, Inc. today announced a license agreement with LEXEO Therapeutics, Inc. (LEXEO), which will enable LEXEO to use Cerveau’s…

Related Keywords

Rick Hiatt , Cerveau Technologies Inc , , Chief Executive Officer , Cerveau Technologies ,